更年期障害治療の世界市場レポート 2025年

更年期障害治療市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は7.4%で、153億米ドルに成長します。予測期間中に予想される成長は、医療インフラ支出の増加、女性の健康への取り組みへの重点化、製薬企業と研究機関の協力関係の増加、更年期の健康に影響を与えるライフスタイルの変化につながる都市化の進展などに起因すると考えられます。この期間に予想される主な動向としては、自然療法やハーブ療法へのシフト、治療計画における人工知能の統合、リアルタイムで症状を追跡できるウェアラブルデバイスの出現、更年期障害に対処するホリスティックウェルネスプログラムの重視、更年期障害関連ソリューションを開発する女性健康関連の新興企業への投資の増加などが挙げられます。

ホルモン補充療法（HRT）に対する需要の高まりは、更年期障害治療市場の拡大を牽引すると予想されます。HRTは、更年期障害やホルモンバランスの乱れに伴う症状を緩和するために、ホルモンを補充または置換する医療プロセスを伴う。HRT使用の増加は、更年期症状やホルモン不均衡の効果的な管理に対する認識と需要の高まりに大きく後押しされています。HRTは、エストロゲンとプロゲステロンのレベルを補充することで更年期障害に対処し、ホルモンバランスの回復を助け、ホットフラッシュ、寝汗、気分の落ち込みなどの不快な症状を緩和し、生活の質を向上させる。例えば、2024年10月、英国を拠点に様々な支援サービスを提供しているNHS Business Services Authority（NHSBSA）は、HRTの処方件数が22％増加し、1,300万件に達したと報告しています。さらに、HRTの適応が確認された患者数は、2022/23年の230万人から2023/24年には260万人へと12%増加しました。このようなホルモン補充療法に対する需要の高まりが、更年期障害治療市場の成長に寄与しています。

更年期障害治療市場の主要企業は、ホルモンを使用せずに血管運動症状を効果的に管理するため、ニューロキニン3（NK3）受容体拮抗薬などの先進的な非ホルモン療法を開発しています。これらの新規療法は、NK3受容体をブロックすることで更年期症状を改善し、従来のホルモン治療に代わる治療法を提供します。例えば、2023年12月、日本の製薬会社であるアステラス製薬は、更年期女性のホットフラッシュや寝汗などの中等度から重度の血管運動症状（VMS）の治療を目的とした非ホルモン性NK3受容体拮抗薬Veozah（フェゾリネタント）の承認を欧州委員会から取得しました。Veozahは、脳の体温調節中枢のニューロンを標的として作用し、これらの症状の頻度と強さを軽減します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場 - 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の更年期障害治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の更年期障害治療市場：成長率分析
• 世界の更年期障害治療市場の実績：規模と成長, 2019-2024
• 世界の更年期障害治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界の更年期障害治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の更年期障害治療市場：治療タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ホルモン補充療法（HRT）
• 非ホルモン治療
• ハーブサプリメント
• ライフスタイルの改善
• 世界の更年期障害治療市場：ステージ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 閉経期
• 閉経後
• 閉経周辺期
• 世界の更年期障害治療市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ホットフラッシュ
• 寝汗
• 気分変動
• 膣の乾燥
• 世界の更年期障害治療市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• その他
• 世界の更年期障害治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 専門クリニック
• 在宅ケア
• その他
• 世界の更年期障害治療市場：ホルモン補充療法（HRT）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• エストロゲン療法
• プロゲステロン療法
• 併用療法
• 経皮パッチ
• 膣エストロゲン
• 経口錠
• 世界の更年期障害治療市場：非ホルモン治療の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 選択的エストロゲン受容体モジュレーター（SERM）
• 抗うつ薬
• ガバペンチン
• クロニジン
• ビスホスホネート
• カルシウム・ビタミンDサプリメント
• 世界の更年期障害治療市場：ハーブサプリメントの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ブラックコホシュ
• レッドクローバー
• ドンクアイ
• 高麗人参
• 大豆イソフラボン
• 亜麻仁
• 世界の更年期障害治療市場：ライフスタイルの改善の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 食生活の変化
• 定期的な運動
• ストレス管理テクニック
• 認知行動療法（CBT）
• 禁煙
• 睡眠衛生の実践

第7章 地域別・国別分析

• 世界の更年期障害治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の更年期障害治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 更年期障害治療市場：競合情勢
• 更年期障害治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bristol-Myers Squibb Company
• Sanofi SA
• AstraZeneca plc
• Eli Lilly and Company
• Novo Nordisk A/S
• Abbott Laboratories
• GlaxoSmithKline plc
• Teva Pharmaceutical Industries Ltd.
• Ipsen SA
• Dr. Reddy's Laboratories Ltd.
• Theramex
• Besins Healthcare
• Mithra Pharmaceuticals
• Duchesnay USA
• Fervent Pharmaceuticals

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 更年期障害治療市場2029：新たな機会を提供する国
• 更年期障害治療市場2029：新たな機会を提供するセグメント
• 更年期障害治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Menopausal disorder treatment encompasses a variety of medical and therapeutic approaches designed to relieve symptoms associated with menopause such as hot flashes, mood fluctuations, sleep issues, and hormonal imbalances aiming to enhance the overall well-being and quality of life for individuals undergoing this transitional phase.

The primary types of menopausal disorder treatments include hormone replacement therapy (HRT), non-hormonal treatments, herbal supplements, and lifestyle changes. Hormone replacement therapy helps regulate hormone levels in women experiencing menopause-related symptoms such as hot flashes, mood swings, and reduced bone density. These treatments are relevant across various stages of the menopausal journey, including perimenopause, menopause, and postmenopause, and are used to address symptoms such as night sweats, mood changes, hot flashes, and vaginal dryness. They are distributed through hospital pharmacies, retail pharmacies, online pharmacies, and other channels, and are utilized by various end users including hospitals, specialty clinics, home care environments, and more.

The menopausal disorder treatment market research report is one of a series of new reports from The Business Research Company that provides menopausal disorder treatment market statistics, including the menopausal disorder treatment industry's global market size, regional shares, competitors with a menopausal disorder treatment market share, detailed menopausal disorder treatment market segments, market trends and opportunities, and any further data you may need to thrive in the menopausal disorder treatment industry. This menopausal disorder treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The menopausal disorder treatment market size has grown strongly in recent years. It will grow from$10.69 billion in 2024 to $11.50 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth during the historic period can be attributed to an aging female population, heightened awareness of menopause-related health concerns, a high prevalence of obesity which can worsen menopausal symptoms, increasing acceptance of hormone replacement therapy (HRT), and advancements in personalized medicine.

The menopausal disorder treatment market size is expected to see strong growth in the next few years. It will grow to$15.30 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth anticipated during the forecast period can be attributed to rising healthcare infrastructure spending, a stronger focus on women's health initiatives, increasing collaborations between pharmaceutical companies and research institutions, and growing urbanization leading to lifestyle changes that affect menopausal health. Key trends expected in this period include a shift toward natural and herbal treatment options, the integration of artificial intelligence in treatment planning, the emergence of wearable devices for real-time symptom tracking, an emphasis on holistic wellness programs addressing menopause, and increased investment in women's health startups developing menopause-related solutions.

The growing demand for hormone replacement therapies (HRT) is expected to drive the expansion of the menopausal disorder treatment market. HRT involves the medical process of supplementing or replacing hormones to alleviate the symptoms associated with menopause or hormonal imbalances. The rise in HRT usage is largely fueled by increasing awareness and demand for effective management of menopausal symptoms and hormonal imbalances. HRT addresses menopausal disorders by replenishing estrogen and progesterone levels, helping to restore hormonal balance and alleviate disruptive symptoms such as hot flashes, night sweats, and mood swings, thus improving the quality of life. For example, in October 2024, the NHS Business Services Authority (NHSBSA), a UK-based organization offering various support services, reported a 22% increase in HRT prescriptions, reaching 13 million items. Additionally, the number of patients identified for HRT rose by 12%, from 2.3 million in 2022/23 to 2.6 million in 2023/24. This growing demand for hormone replacement therapies is contributing to the growth of the menopausal disorder treatment market.

Leading companies in the menopausal disorder treatment market are developing advanced nonhormonal therapies, such as neurokinin 3 (NK3) receptor antagonist drugs, to effectively manage vasomotor symptoms without the use of hormones. These novel therapies work by blocking NK3 receptors to manage menopausal symptoms, providing an alternative to traditional hormone treatments. For instance, in December 2023, Astellas Pharma Inc., a Japan-based pharmaceutical company, received approval from the European Commission for Veozah (fezolinetant), a non-hormonal NK3 receptor antagonist aimed at treating moderate to severe vasomotor symptoms (VMS), including hot flashes and night sweats in menopausal women. Veozah operates by targeting neurons in the brain's temperature regulation center, reducing the frequency and intensity of these symptoms.

In October 2022, Unified Women's Healthcare, a US-based company specializing in comprehensive women's health services, acquired Gennev for an undisclosed amount. This acquisition strengthens Unified Women's Healthcare's position in menopause care in the U.S. by expanding its digital health offerings and improving access to specialized care for women experiencing menopause. Gennev is a US-based digital health platform offering personalized and comprehensive menopause treatment services.

Major players in the menopausal disorder treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co Inc., Novartis AG, Bayer AG, Bristol-Myers Squibb Company, Sanofi SA, AstraZeneca plc, Eli Lilly and Company, Novo Nordisk A/S, Abbott Laboratories, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Ipsen SA, Dr. Reddy's Laboratories Ltd., Theramex, Besins Healthcare, Mithra Pharmaceuticals, Duchesnay USA, Fervent Pharmaceuticals, Joylux Inc., and TherapeuticsMD Inc.

North America was the largest region in the menopausal disorder treatment market in 2024. The regions covered in menopausal disorder treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the menopausal disorder treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The menopausal disorder treatment market includes revenues earned by entities providing services such as estrogen-only therapy, combined estrogen and progesterone therapy, bone health management, and hormone level testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The menopausal disorder treatment market also includes sales of hormone replacement therapy (HRT) medications, non-hormonal therapies, dietary supplements, and vaginal estrogen products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Menopausal Disorder Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on menopausal disorder treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for menopausal disorder treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The menopausal disorder treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Hormone Replacement Therapy; Non-Hormonal Treatment; Herbal Supplements; Lifestyle Modifications
• 2) By Stages: Menopause; Postmenopause; Perimenopause
• 3) By Application: Hot Flashes; Night Sweats; Mood Swings; Vaginal Dryness
• 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels
• 5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users
• Subsegments:
• 1) By Hormone Replacement Therapy (HRT): Estrogen Therapy; Progesterone Therapy; Combination Therapy; Transdermal Patches; Vaginal Estrogen; Oral Tablets
• 2) By Non-Hormonal Treatment: Selective Estrogen Receptor Modulators (SERMs); Antidepressants; Gabapentin; Clonidine; Bisphosphonates; Calcium And Vitamin D Supplements
• 3) By Herbal Supplements: Black Cohosh; Red Clover; Dong Quai; Ginseng; Soy Isoflavones; Flaxseed
• 4) By Lifestyle Modifications: Dietary Changes; Regular Physical Exercise; Stress Management Techniques; Cognitive Behavioral Therapy (CBT); Smoking Cessation; Sleep Hygiene Practices
• Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd; Merck & Co Inc.; Novartis AG; Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Menopausal Disorder Treatment Market Characteristics

3. Menopausal Disorder Treatment Market Trends And Strategies

4. Menopausal Disorder Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Menopausal Disorder Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Menopausal Disorder Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Menopausal Disorder Treatment Market Growth Rate Analysis
• 5.4. Global Menopausal Disorder Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Menopausal Disorder Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Menopausal Disorder Treatment Total Addressable Market (TAM)

6. Menopausal Disorder Treatment Market Segmentation

• 6.1. Global Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hormone Replacement Therapy
• Non-Hormonal Treatment
• Herbal Supplements
• Lifestyle Modifications
• 6.2. Global Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Menopause
• Postmenopause
• Perimenopause
• 6.3. Global Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hot Flashes
• Night Sweats
• Mood Swings
• Vaginal Dryness
• 6.4. Global Menopausal Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Other Distribution Channels
• 6.5. Global Menopausal Disorder Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Homecare
• Other End-Users
• 6.6. Global Menopausal Disorder Treatment Market, Sub-Segmentation Of Hormone Replacement Therapy (HRT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Estrogen Therapy
• Progesterone Therapy
• Combination Therapy
• Transdermal Patches
• Vaginal Estrogen
• Oral Tablets
• 6.7. Global Menopausal Disorder Treatment Market, Sub-Segmentation Of Non-Hormonal Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Selective Estrogen Receptor Modulators (SERMs)
• Antidepressants
• Gabapentin
• Clonidine
• Bisphosphonates
• Calcium And Vitamin D Supplements
• 6.8. Global Menopausal Disorder Treatment Market, Sub-Segmentation Of Herbal Supplements, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Black Cohosh
• Red Clover
• Dong Quai
• Ginseng
• Soy Isoflavones
• Flaxseed
• 6.9. Global Menopausal Disorder Treatment Market, Sub-Segmentation Of Lifestyle Modifications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dietary Changes
• Regular Physical Exercise
• Stress Management Techniques
• Cognitive Behavioral Therapy (CBT)
• Smoking Cessation
• Sleep Hygiene Practices

7. Menopausal Disorder Treatment Market Regional And Country Analysis

• 7.1. Global Menopausal Disorder Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Menopausal Disorder Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Menopausal Disorder Treatment Market

• 8.1. Asia-Pacific Menopausal Disorder Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Menopausal Disorder Treatment Market

• 9.1. China Menopausal Disorder Treatment Market Overview
• 9.2. China Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Menopausal Disorder Treatment Market

• 10.1. India Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Menopausal Disorder Treatment Market

• 11.1. Japan Menopausal Disorder Treatment Market Overview
• 11.2. Japan Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Menopausal Disorder Treatment Market

• 12.1. Australia Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Menopausal Disorder Treatment Market

• 13.1. Indonesia Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Menopausal Disorder Treatment Market

• 14.1. South Korea Menopausal Disorder Treatment Market Overview
• 14.2. South Korea Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Menopausal Disorder Treatment Market

• 15.1. Western Europe Menopausal Disorder Treatment Market Overview
• 15.2. Western Europe Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Menopausal Disorder Treatment Market

• 16.1. UK Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Menopausal Disorder Treatment Market

• 17.1. Germany Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Menopausal Disorder Treatment Market

• 18.1. France Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Menopausal Disorder Treatment Market

• 19.1. Italy Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Menopausal Disorder Treatment Market

• 20.1. Spain Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Menopausal Disorder Treatment Market

• 21.1. Eastern Europe Menopausal Disorder Treatment Market Overview
• 21.2. Eastern Europe Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Menopausal Disorder Treatment Market

• 22.1. Russia Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Menopausal Disorder Treatment Market

• 23.1. North America Menopausal Disorder Treatment Market Overview
• 23.2. North America Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Menopausal Disorder Treatment Market

• 24.1. USA Menopausal Disorder Treatment Market Overview
• 24.2. USA Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Menopausal Disorder Treatment Market

• 25.1. Canada Menopausal Disorder Treatment Market Overview
• 25.2. Canada Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Menopausal Disorder Treatment Market

• 26.1. South America Menopausal Disorder Treatment Market Overview
• 26.2. South America Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Menopausal Disorder Treatment Market

• 27.1. Brazil Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Menopausal Disorder Treatment Market

• 28.1. Middle East Menopausal Disorder Treatment Market Overview
• 28.2. Middle East Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Menopausal Disorder Treatment Market

• 29.1. Africa Menopausal Disorder Treatment Market Overview
• 29.2. Africa Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Menopausal Disorder Treatment Market Competitive Landscape And Company Profiles

• 30.1. Menopausal Disorder Treatment Market Competitive Landscape
• 30.2. Menopausal Disorder Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Menopausal Disorder Treatment Market Other Major And Innovative Companies

• 31.1. Bristol-Myers Squibb Company
• 31.2. Sanofi SA
• 31.3. AstraZeneca plc
• 31.4. Eli Lilly and Company
• 31.5. Novo Nordisk A/S
• 31.6. Abbott Laboratories
• 31.7. GlaxoSmithKline plc
• 31.8. Teva Pharmaceutical Industries Ltd.
• 31.9. Ipsen SA
• 31.10. Dr. Reddy's Laboratories Ltd.
• 31.11. Theramex
• 31.12. Besins Healthcare
• 31.13. Mithra Pharmaceuticals
• 31.14. Duchesnay USA
• 31.15. Fervent Pharmaceuticals

32. Global Menopausal Disorder Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Menopausal Disorder Treatment Market

34. Recent Developments In The Menopausal Disorder Treatment Market

35. Menopausal Disorder Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Menopausal Disorder Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Menopausal Disorder Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Menopausal Disorder Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer